Gsk (GSK) Current Deferred Revenue (2016 - 2018)
Gsk (GSK) posted quarterly Current Deferred Revenue of $277.9 million for Q4 2018, down 12.77% year-over-year from $318.6 million in Q4 2017, and down 12.77% quarter-over-quarter from $318.6 million in Q4 2017.
Gsk (GSK) Current Deferred Revenue (2016 - 2018) Analysis & Trends
Gsk's Current Deferred Revenue history runs 3 years deep, the most recent figure standing at $277.9 million for Q4 2018.
- In Q4 2018, Current Deferred Revenue fell 12.77% year-over-year to $277.9 million; the TTM figure through Dec 2018 stood at $277.9 million (down 12.77% YoY), while the FY2018 annual figure was $288.5 million, down 6.69% from the prior year.
- Current Deferred Revenue for Q4 2018 stood at $277.9 million, down from $318.6 million in the prior quarter.
- The five-year high for Current Deferred Revenue was $318.6 million in Q4 2017, with the low at $82.1 million in Q4 2016.
- The 3-year median for Current Deferred Revenue is $277.9 million (2018), against an average of $226.2 million.
- The sharpest annual moves came in 2017 and 2018: Current Deferred Revenue soared 288.34% in 2017, then retreated 12.77% in 2018.
- Gsk's Current Deferred Revenue stood at $82.1 million in 2016, then jumped by 288.34% to $318.6 million in 2017, then fell by 12.77% to $277.9 million in 2018.
- Business Quant data shows GSK's Current Deferred Revenue at $277.9 million in Q4 2018, $318.6 million in Q4 2017, and $82.1 million in Q4 2016.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 652.20 Bn | 631.44 Bn | 17.26 Bn |
| 2 | AbbVie | 469.51 Bn | 462.94 Bn | 12.70 Bn |
| 3 | Merck | 376.81 Bn | 369.67 Bn | 12.21 Bn |
| 4 | Novartis Ag | 303.04 Bn | 295.35 Bn | 11.24 Bn |
| 5 | Astrazeneca | 257.61 Bn | 252.71 Bn | 12.86 Bn |
| 6 | Amgen | 237.37 Bn | 223.38 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 181.73 Bn | 178.55 Bn | 6.22 Bn |
| 8 | Pfizer | 159.66 Bn | 147.96 Bn | 10.94 Bn |
| 9 | Gsk | 106.24 Bn | 102.07 Bn | 8.24 Bn |
| 10 | Sanofi | 55.07 Bn | 47.69 Bn | 10.79 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2018 | 277.94 Mn |
| Dec 31, 2017 | 318.64 Mn |
| Dec 31, 2016 | 82.05 Mn |